{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:10:04Z","timestamp":1791054604923,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T00:00:00Z","timestamp":1129852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> BK virus allograft nephropathy (BKVAN) is a rising complication in kidney transplant recipients. Reducing immunosuppression has been the initial form of therapy in most cases, but is not always associated with improvement in graft function. Anti\u2010viral therapy with low\u2010dose cidofovir (0.25\u20130.42\u2003mg\/kg\/dose) has been used successfully in some patients, but dose\u2010related nephrotoxicity has limited its use. We present our experience with 3 kidney transplant recipients diagnosed with BKVAN who received intermediate\u2010dose cidofovir (0.75\u20131.0\u2003mg\/kg\/dose) without probenecid, and without concomitant nephrotoxicity. Three female patients, ages 8, 19 and 20\u2003yr, presented with elevated serum creatinine (SCr) values, BK virus stain positive on renal biopsy and high plasma BK viral loads. As a result of viral loads being &gt;2\u2003million copies\/ml in two patients and a lack of response to reduction in immunosuppression in the third, we initiated therapy with low\u2010dose cidofovir. Because of persistent positive BK stain and positive plasma viral load, we then administered intermediate\u2010dose cidofovir, without probenecid, for several subsequent doses (seven to 15 infusions till date). All patients tolerated the intermediate\u2010dose cidofovir with no significant rise in SCr during the course of the infusions. The most recent SCr values in all three patients were improved from those at the initial diagnosis of BKVAN. All three patients showed a marked drop in BK viral loads when on intermediate\u2010dose cidofovir, with complete clearing of viremia in two patients. In our experience, intermediate\u2010dose cidofovir without probenecid, used judiciously, is not associated with additional nephrotoxicity and may provide an additional alternative for treatment.<\/jats:p>","DOI":"10.1111\/j.1399-3046.2005.00391.x","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T15:28:27Z","timestamp":1129908507000},"page":"32-37","source":"Crossref","is-referenced-by-count":43,"title":["Intermediate\u2010dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy"],"prefix":"10.1111","volume":"10","author":[{"given":"Carlos E.","family":"Araya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy F.","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"III Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Neiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas R.","family":"Dharnidharka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,21]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/321813"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)91776-4"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/128.6.784"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5858\/2005-129-69-KAUTPI","article-title":"Kidney and urinary tract polyomavirus infection and distribution: molecular biology investigation of 10 consecutive autopsies","volume":"129","author":"Boldorini R","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/147.4.676"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg072"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000023435.07320.81"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00350.x"},{"key":"e_1_2_5_10_2","first-page":"19","article-title":"Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes\u2010, papova\u2010, pox\u2010 and adenovirus) infections","volume":"58","author":"De Clercq E","year":"1996","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"e_1_2_5_11_2","first-page":"315","article-title":"Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits","volume":"24","author":"Cundy KC","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.587"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199804010-00008"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg061"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2008.00214.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.30202.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.11.2023"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200301150-00020"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00585.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.37.5.578"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2003.00009.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200212150-00004"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000113163.02039.30"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199901150-00018"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199911150-00011"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200311000-00005"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V113383"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200306000-00006"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2005.00391.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3046.2005.00391.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T17:22:01Z","timestamp":1696958521000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2005.00391.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1111\/j.1399-3046.2005.00391.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2005.00391.x","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,21]]}}}